24°

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
News
- Local News
- State News
Sports
- Local Sports
- Pro Sports
Lifestyle
- Local Entertainment
Multimedia
Community Choice
Features
Classifieds
- Place Ad
- Legal Notices
Public Notices
Obituaries
E-Edition

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Pasithea Therapeutics Corp. - Common Stock (NQ:KTTA)

0.7512 -0.0488 (-6.10%)

Streaming Delayed Price Updated: 1:47 PM EST, Feb 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pasithea Therapeutics Corp. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 23, 2021

Gainers Pasithea Therapeutics (NASDAQ:KTTA

Via Benzinga

Mid-Day Market Update: Nasdaq Tumbles Over 200 Points; Pasithea Therapeutics Shares Surge ↗

November 23, 2021

Midway through trading Tuesday, the Dow traded down 0.19% to 35,550.02 while the NASDAQ fell 1.45% to 15,624.16. The S&P also fell, dropping 0.63% to 4,653.33. The U.S. has...

Via Benzinga

Topics Stocks

Nasdaq Sharply Lower as Tech Selloff Weighs ↗

November 23, 2021

The Nasdaq Composite is sharply lower midday, as the tech selloff weighs on the benchmark, while the Dow Jones Industrial Average is up roughly 35 points, and the S&P 500 sits modestly in the red.

Via Talk Markets

Topics Stocks

36 Stocks Moving In Tuesday's Mid-Day Session ↗

November 23, 2021

Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) shares jumped 216.6% to $7.00 after the company announced its subsidiary Pasithea Clinics has been approved to provide...

Via Benzinga

DKS Stock: 14 Reasons Why Dick’s Sporting Goods Investors Are Taking an L Today ↗

November 23, 2021

Dick's Sporting Goods (DKS) stock isn't doing so hot on Tuesday following the release of its earnings report for the third quarter of 2021.

Via InvestorPlace

PTPI Stock: 11 Things to Know About Penny Stock Petros Pharmaceuticals as Shares Rocket 100%+ ↗

November 23, 2021

Petros Pharmaceuticals (PTPI) stock is surging higher on Tuesday following a filing with the U.S. Securities and Exchange Commission (SEC).

Via InvestorPlace

DLTR Stock Alert: The Dollar Tree Price Hike Giving Shares a Bump Today ↗

November 23, 2021

Dollar Tree (DLTR) stock is heading higher Tuesday after the company saw positive results from its recent price increase tests.

Via InvestorPlace

KTTA Stock: The Depression Nasal Spray News That Has Pasithea Therapeutics Investors Ecstatic Today ↗

November 23, 2021

Pasithea Therapeutics (KTTA) stock is rocketing higher on Tuesday after adding esketamine nasal spray to its U.K. offerings.

Via InvestorPlace

Mid-Morning Market Update: Markets Mostly Lower; Best Buy Posts Upbeat Q3 Earnings ↗

November 23, 2021

Following the market opening Tuesday, the Dow traded up 0.02% to 35,627.53 while the NASDAQ fell 0.58% to 15,762.28. The S&P also fell, dropping 0.14% to 4,676.49. The U.S....

Via Benzinga

Topics Stocks

Intranasal Ketamine Garnering A lot of Attention as an Effective Treatment For Depression

November 23, 2021

Palm Beach, FL –November 23, 2021 – FinancialNewsMedia.com News Commentary – The COVID-19 pandemic is expected to have a significant positive impact on the growth of the global antidepressant market....

Via FinancialNewsMedia

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 23, 2021

Gainers Pasithea Therapeutics (NASDAQ:KTTA) stock increased by 157.46% to $5.69 during Tuesday's pre-market session. The company's market cap stands at $75.1...

Via Benzinga

EXCLUSIVE: Pasithea's Depression Treatment, Esketamine Nasal Spray Added In Clinic Offerings In UK ↗

November 23, 2021

Pasithea Therapeutics Corp's (NASDAQ: KTTA) wholly-owned subsidiary, Pasithea Clinics, has been approved to provide esketamine nasal spray (Spravato) for treatment-resistant...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 22, 2021

Gainers Qualigen Therapeutics (NASDAQ:QLGN

Via Benzinga

44 Stocks Moving In Thursday's Mid-Day Session ↗

November 18, 2021

Gainers Longeveron Inc. (NASDAQ: LGVN) jumped 157% to $7.51. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 18, 2021

Gainers Dicerna Pharmaceuticals (NASDAQ:DRNA) stock increased by 78.28% to $37.94 during Thursday's pre-market session. The market value of their outstanding shares is...

Via Benzinga

Mobile Mental Health: Coming to a Home Near You? ↗

November 18, 2021

Photo by Anna Shvets from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

November 18, 2021

Good morning, investor! We're getting right into the thick of it today with a look at the biggest pre-market stock movers for Thursday!

Via InvestorPlace

24 Stocks Moving in Thursday's Pre-Market Session ↗

November 18, 2021

Gainers Sono Group N.V. (NASDAQ: SEV) rose 33% to $50.80 in pre-market trading. Sono Group shares climbed 155% on Wednesday after the company priced its IPO at $15 per share....

Via Benzinga

Topics Initial Public Offering

Use of Ketamine for Mental Disorders Rising While New Therapies Emerge

November 17, 2021

Palm Beach, FL –November 17, 2021 – FinancialNewsMedia.com News Commentary – The uses of Ketamine for a variety of therapies are growing. An expanding number of clinics are offering ketamine infusion...

Via FinancialNewsMedia

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 17, 2021

Gainers Rockwell Medical (NASDAQ:RMTI) shares rose 47.27% to $0.71 during Wednesday's pre-market session. The company's market cap stands at $66.5 million. The...

Via Benzinga

EXCLUSIVE: Pasithea Clinics Launches In-Home Intravenous Ketamine Therapy In Major US Cities ↗

November 17, 2021

Pasithea Therapeutics Corp. (NASDAQ:KTTA), a biotechnology...

Via Benzinga

This Company Wants To Deliver Better Mental Health Straight to Your Door ↗

November 10, 2021

Photo by Thirdman from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner...

Via Benzinga

Knock, Knock: It's 2021, and Mental Health Is at Your Door ↗

November 05, 2021

Photo by Mo on Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of...

Via Benzinga

64 Biggest Movers From Yesterday ↗

November 02, 2021

Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 01, 2021

Gainers Artelo Biosciences (NASDAQ:ARTL) stock moved upwards by 55.11% to $1.11 during Monday's regular session. As of 12:30 EST, this security is trading at a volume...

Via Benzinga

Pasithea and Evotec Team Up — Attempt to Make Headway on Brain Disorders ↗

November 01, 2021

Photo by Karolina Grabowska from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 28, 2021

Gainers Medigus (NASDAQ:MDGS) shares moved upwards by 12.04% to $1.62 during Thursday's pre-market session. The market value of their outstanding shares is at $38.6...

Via Benzinga

30 Stocks Moving in Thursday's Pre-Market Session ↗

October 28, 2021

Gainers InflaRx N.V. (NASDAQ: IFRX) rose 47.9% to $4.23 in pre-market trading. Raymond James upgraded InflaRx from Outperform to Strong Buy and announced a $14 price target....

Via Benzinga

Biotech Companies Are Embracing the Growing Psychedelic Drug Market To Confront a Global Increase in Depression and Anxiety ↗

October 27, 2021

Image by 3D Animation Production Company from Pixabay The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team...

Via Benzinga

Ketamine’s Potential As A Treatment For Depression Has Drawn Major Industry Attention

October 27, 2021

Palm Beach, FL –October 27, 2021 – FinancialNewsMedia.com News Commentary – Among the race to see what psychedelic drugs can do, ketamine is a step ahead of all other drugs, because it has already been...

Via FinancialNewsMedia

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Multimedia
Local Events
Classifieds
Obituaries
Weather
Online Features

Services

About Us
Contact Us
Promote Your Event
Subscriber Services
Online Forms
Rack Locations

woonsocketcall.com
Address: 154 Main Street
Woonsocket, RI 02895
Phone: 401-762-3000
Email: notices@woonsocketcall.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Pasithea Therapeutics Corp. - Common Stock (NQ:KTTA)

All News about Pasithea Therapeutics Corp. - Common Stock

Sections

Services